Page 90 – Channelchek

Release – Century Lithium and Orica Specialty Mining Chemicals Sign MOU for Sodium Hydroxide From Angel Island

Posted on January 21, 2025January 21, 2025 by aweinsoff@channelchek.com

January 21, 2025 – Vancouver, Canada – Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) (Century Lithium) is pleased to announce it signed a non-binding memorandum of understanding (MOU) with Orica Specialty Mining Chemicals (Orica) on January 16, 2025. The non-binding MOU outlines the intent of Century Lithium and Orica to formalize a multiyear offtake agreement for Orica to purchase sodium hydroxide (NaOH) from Century Lithium’s wholly owned Angel Island project near Silver Peak, Nevada. Orica is one of the world’s leading mining and infrastructure solutions providers, and a major US manufacturer and supplier of specialty mining chemicals to Nevada’s mining industry.

“The non-binding MOU with Orica marks a key milestone for Angel Island,” said Century Lithium President and CEO, Bill Willoughby. “The MOU outlines the first expected agreement of its kind for the project and involves a large portion of the surplus sodium hydroxide anticipated during the early years of operation. We are excited to work with Orica and have their support at this stage of development at Angel Island.”

Orica President Specialty Mining Chemicals Andrew Stewart said: “This collaboration signifies our commitment to strengthening and unlocking Nevada’s manufacturing and mining sectors. By securing a reliable source of sodium hydroxide from Angel Island, we strengthen the local supply chain and reinforce our dedication to innovative US manufacturing solutions for our customers in North America.”

Century Lithium patent-pending process for extracting lithium from the claystone at Angel Island combines chloride leaching with direct lithium extraction and uses salt, in the form of solid sodium chloride or saline brine, to make the reagents for leaching and pH control. In addition to lithium, the process produces surplus sodium hydroxide, the sales of which are anticipated to underpin low operating costs for Angel Island’s primary product, lithium carbonate.

Highlights of MOU

Century Lithium to intends to provide Orica membrane-grade sodium hydroxide (NaOH)
Initial 5-year term, right of first offer for an additional 5 years
Pricing to be determined by definitive agreement
Orica – Century Lithium relationship will strengthen the U.S. supply chain, reducing reliance on imports of NaOH to the western U.S. and supporting Nevada’s mining industry

ABOUT ORICA

Orica (ASX: ORI) is one of the world’s leading mining and infrastructure solutions providers. From the production and supply of explosives, blasting systems, specialty mining chemicals and geotechnical monitoring to our cutting-edge digital solutions and comprehensive range of services, we sustainably mobilize the earth’s resources.

Operating for more than 150 years, today our 14,000+ global workforce supports customers across surface and underground mines, quarry, construction, and oil and gas operations.

With a sodium cyanide manufacturing plants located in Winnemucca, Nevada and Alvin Texas, Orica is now the world’s largest producer of sodium cyanide and supplier to the Nevada mining industry, a leader in U.S. gold production. Find out more about Orica: www.orica.com

ABOUT CENTURY LITHIUM CORP.

Century Lithium Corp. is an advanced stage lithium company, focused on developing its wholly-owned Angel Island project in Esmeralda County, Nevada, which hosts one of the largest sedimentary lithium deposits in the United States. The Company has utilized its patent-pending process for chloride leaching combined with direct lithium extraction to make high purity lithium carbonate product samples from Angel Island lithium-bearing claystone on-site at its Pilot Plant in Amargosa Valley, Nevada.

Angel Island is one of the few advanced lithium projects in development in the United States to provide an end-to-end process to produce battery quality lithium carbonate for the growing electric vehicle and battery storage market. Angel Island is currently in the permitting stage for a three-phase feasibility-level production plan expected to yield an average of 34,000 tonnes per year of lithium carbonate over a 40-year mine-life.

Century Lithium trades on both the TSX Venture Exchange under the symbol “LCE” and the OTCQX under the symbol “CYDVF”; and on the Frankfurt Stock Exchange under the symbol “C1Z”. To learn more, please visit: centurylithium.com

ON BEHALF OF CENTURY LITHIUM CORP.
WILLIAM WILLOUGHBY, PhD., PE
President & Chief Executive Officer

For further information, please contact:
Spiros Cacos | Vice President, Investor Relations
Direct: +1 604 764 1851
Toll Free: 1 800 567 8181
scacos@centurylithium.com
centurylithium.com

Andrew Valler | Head of Communications
Direct: +61 437 829 211
andrew.valler@orica.com
orica.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THE CONTENT OF THIS NEWS RELEASE.

Cautionary Note Regarding Forward-Looking Statements

This release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. In certain cases, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” and similar expressions suggesting future outcomes or statements regarding an outlook.

Forward-looking statements relate to any matters that are not historical facts and statements of our beliefs, intentions and expectations about developments, results and events which will or may occur in the future, without limitation, statements with respect to the potential development and value of the Project and benefits associated therewith, statements with respect to the expected project economics for the Project, such as estimates of life of mine, lithium prices, production and recoveries, capital and operating costs, IRR, NPV and cash flows, any projections outlined in the Feasibility Study in respect of the Project, the permitting status of the Project and the Company’s future development plans.

These and other forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause their actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out herein. These risks include those described under the heading “Risk Factors” in the Company’s most recent annual information form and its other public filings, copies of which can be under the Company’s profile at www.sedarplus.com. The Company expressly disclaims any obligation to update-forward-looking information except as required by applicable law. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place reliance on forward-looking statements or information. Furthermore, Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.

Release – Bitcoin Depot Reports Strong Preliminary Fourth Quarter 2024 Results

Posted on January 21, 2025January 21, 2025 by aweinsoff@channelchek.com

Research News and Market Data on BTM

January 21, 2025 8:00 AM EST Download as PDF

Q4 2024 Results Signal Strength and Momentum for 2025

ATLANTA, Jan. 21, 2025 (GLOBE NEWSWIRE) — Bitcoin Depot Inc. (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and leading fintech company, today announced certain preliminary financial results for the fourth quarter ended December 31, 2024.

The Company expects revenue to range between $135 million and $137 million, compared to $135.3 million reported in the third quarter of 2024 and $148.4 million reported in the fourth quarter of 2023. The Company also expects adjusted EBITDA to range between $11 million and $13 million, an increase of 22% to 44% compared to the $9.0 million reported in the fourth quarter of 2023 and an increase of 19% to 41% compared to the $9.2 million reported in the third quarter of 2024.

“We ended 2024 on a strong note, with an anticipated uptick in sequential revenue and significant improvements in adjusted EBITDA on both a sequential and year-over-year basis,” said Brandon Mintz, CEO and Founder of Bitcoin Depot. “This performance reflects the expansion of our BTM network and our progress in improving kiosk profitability. The strength of our fourth quarter positions us well for a rebound in 2025, supported by the overall health of our business and a more favorable cryptocurrency market environment.”

The financial results for the fourth quarter ended December 31, 2024, included in this release are preliminary, have not been reviewed or audited, are based upon the Company’s estimates, and were prepared prior to the completion of the company’s financial statement close process. The preliminary financial results should not be viewed as a substitute for the Company’s full fourth quarter results and do not present all information necessary for an understanding of the Company’s financial performance. Accordingly, undue reliance should not be placed on this preliminary data. Bitcoin Depot plans to release its fully audited fourth-quarter and full-year 2024 financial results in March.

About Bitcoin Depot

Bitcoin Depot Inc. (Nasdaq: BTM) was founded in 2016 with the mission to connect those who prefer to use cash to the broader, digital financial system. Bitcoin Depot provides its users with simple, efficient and intuitive means of converting cash into Bitcoin, which users can deploy in the payments, spending and investing space. Users can convert cash to bitcoin at Bitcoin Depot kiosks in 48 states and at thousands of name-brand retail locations in 29 states through its BDCheckout product. The Company has the largest market share in North America with approximately 8,400 kiosk locations as of December 31, 2024. Learn more at www.bitcoindepot.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release and any oral statements made in connection herewith include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. Forward-looking statements are any statements other than statements of historical fact, and include, but are not limited to, statements regarding the expectations of plans, business strategies, objectives and growth and anticipated financial and operational performance, including our growth strategy and ability to increase deployment of our products and services, our ability to strengthen our financial profile, and worldwide growth in the adoption and use of cryptocurrencies. These forward-looking statements are based on management’s current beliefs, based on currently available information, as to the outcome and timing of future events. Forward-looking statements are often identified by words such as “anticipate,” “appears,” “approximately,” “believe,” “continue,” “could,” “designed,” “effect,” “estimate,” “evaluate,” “expect,” “forecast,” “goal,” “initiative,” “intend,” “may,” “objective,” “outlook,“ ”plan,“ ”potential,“ ”priorities,“ ”project,“ ”pursue,“ ”seek,“ ”should,“ ”target,“ ”when,“ ”will,“ ”would,” or the negative of any of those words or similar expressions that predict or indicate future events or trends or that are not statements of historical matters, although not all forward-looking statements contain such identifying words. In making these statements, we rely upon assumptions and analysis based on our experience and perception of historical trends, current conditions, and expected future developments, as well as other factors we consider appropriate under the circumstances. We believe these judgments are reasonable, but these statements are not guarantees of any future events or financial results. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond our control.

These forward-looking statements are subject to a number of risks and uncertainties, including changes in domestic and foreign business, market, financial, political and legal conditions; failure to realize the anticipated benefits of the business combination; risks relating to the uncertainty of our projected financial information; future global, regional or local economic and market conditions; the development, effects and enforcement of laws and regulations; our ability to manage future growth; our ability to develop new products and services, bring them to market in a timely manner and make enhancements to our platform; the effects of competition on our future business; our ability to issue equity or equity-linked securities; the outcome of any potential litigation, government and regulatory proceedings, investigations and inquiries; and those factors described or referenced in filings with the Securities and Exchange Commission. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that we do not presently know or that we currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect our expectations, plans or forecasts of future events and views as of the date of this press release. We anticipate that subsequent events and developments will cause our assessments to change.

We caution readers not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other factors that affect the subject of these statements, except where we are expressly required to do so by law. All written and oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary statement.

Use of non-GAAP Financial Measures

This press release includes preliminary Adjusted EBITDA results for the fourth quarter ended December 31, 2025. Adjusted EBITDA is a non-GAAP. Bitcoin Depot defines Adjusted EBITDA as net income before interest expense, income tax expense, depreciation and amortization, non-recurring expenses, share-based compensation, expenses related to the PIPE financing and miscellaneous cost adjustments. Such items are excluded from Adjusted EBITDA because these items are non-cash in nature, or because the amount and timing of these items is unpredictable, not driven by core results of operations and renders comparisons with prior periods and competitors less meaningful. Bitcoin Depot believes Adjusted EBITDA provides useful information to investors and others in understanding and evaluating Bitcoin Depot’s results of operations, as well as provides a useful measure for period-to-period comparisons of Bitcoin Depot’s business performance. Adjusted EBITDA is a key measurements used internally by management to make operating decisions, including those related to operating expenses, evaluate performance and perform strategic and financial planning. However, you should be aware that Adjusted EBITDA may exclude items that are significant in understanding and assessing Bitcoin Depot’s financial results, and further, that Bitcoin Depot may incur future expenses similar to those excluded when calculating this measures. Bitcoin Depot primarily relies on GAAP results and relies on Adjusted EBITDA and other non-GAAP measures on a supplemental basis. No such measure should be considered in isolation from, or as an alternative to, net income, cash flows from operations or other measures of profitability, liquidity or performance under GAAP and may not be indicative of Bitcoin Depot’s historical or future operating results. Bitcoin Depot’s computation of Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies because not all companies calculate such measures in the same fashion. As such, undue reliance should not be placed on such measures. Due to some of the information excluded from Adjusted EBITDA calculation being non-ascertainable or non-accessible until the financial close is complete, Bitcoin Depot is unable to quantify certain amounts that would be required to be included in the most directly comparable GAAP financial measures without unreasonable effort. Consequently, no disclosure of estimated comparable GAAP measures is included and no reconciliation of the non-GAAP financial measures is included.

Contacts:

Investors 
Cody Slach
Gateway Group, Inc. 
949-574-3860 
BTM@gateway-grp.com

Media 
Brenlyn Motlagh, Ryan Deloney 
Gateway Group, Inc.
949-574-3860 
BTM@gateway-grp.com

Source: Bitcoin Depot Inc.

Released January 21, 2025

Release – Alliance Resource Partners, L.P. Announces Fourth Quarter 2024 Earnings Conference Call

Posted on January 21, 2025January 21, 2025 by aweinsoff@channelchek.com

Research News and Market Data on ARLP

January 20, 2025

Download(opens in new window)

TULSA, Okla.–(BUSINESS WIRE)– Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its fourth quarter 2024 financial results before the market opens on Monday, February 3, 2025. Alliance management will discuss these results during a conference call beginning at 10:00 a.m. Eastern that same day.

To participate in the conference call, dial U.S. Toll Free (877) 407-0784 and request to be connected to the Alliance Resource Partners, L.P. earnings conference call. International callers should dial (201) 689-8560 and request to be connected to the same call. Investors may also listen to the call via the “Investors” section of ARLP’s website at www.arlp.com.

An audio replay of the conference call will be available for approximately one week. To access the audio replay, dial U.S. Toll Free (844) 512-2921; International Toll (412) 317-6671 and request to be connected to replay using access code 13750955.

About Alliance Resource Partners, L.P.

ARLP is a diversified energy company that is currently the largest coal producer in the eastern United States, supplying reliable, affordable energy domestically and internationally to major utilities, metallurgical and industrial users. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is evolving and positioning itself as a reliable energy partner for the future by pursuing opportunities that support the advancement of energy and related infrastructure.

News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7673 or via e-mail at investorrelations@arlp.com.

Cary P. Marshall
Senior Vice President and Chief Financial Officer
(918) 295-7673
investorrelations@arlp.com

Source: Alliance Resource Partners, L.P.

GeoVax Labs (GOVX) – Gedeptin To Begin Phase 2 Clinical Trial

Posted on January 21, 2025January 21, 2025 by cpereira@noblefcm.com

Tuesday, January 21, 2025

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the world’s most threatening infectious diseases. The company’s lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax’s lead infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine targeting high-risk immunocompromised patient populations. Currently in three Phase 2 clinical trials, GEO-CM04S1 is being evaluated as a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, and as a booster vaccine in patients with chronic lymphocytic leukemia (CLL). In addition, GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. GeoVax has a leadership team who have driven significant value creation across multiple life science companies over the past several decades.

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

GeoVax Starts The Year By Announcing Phase 2 Trial For Gedeptin. GeoVax has announced that a Phase 2 trial for Gedeptin, its gene therapy for delivering cytotoxic cancer drugs, is planned to start in 1H25. As we expected, the trial will test Gedeptin with a checkpoint inhibitor in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).

Gedeptin Delivers A Gene To Activate The Cancer Drug In The Tumor. Gedeptin is based on the Gene-Directed Enzyme Prodrug Therapy (GDEPT) technology platform. It uses an adenovirus vector to deliver the E. coli PNP gene to cancer cells. Once inside the cells, the gene produces an enzyme that converts an inactive prodrug (fludarabine) into an active cytotoxic drug. This increases the drug’s potency inside the cancer cells while avoiding healthy tissue. Gedeptin has completed Phase 1/2 trials in advanced head and neck cancer and has been granted Orphan Drug Designation for oral and pharyngeal cancers.

Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.

Euroseas (ESEA) – Vessel Sale Adds a New Wrinkle to the Proposed Euroholdings Ltd. Spin-Off

Posted on January 21, 2025January 21, 2025 by cpereira@noblefcm.com

Tuesday, January 21, 2025

Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA. Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Sale of the M/V Diamantis P. A wholly owned subsidiary of Euroseas sold the M/V Diamantis P for ~$13.2 million and delivered the vessel to its new owners on January 15. Recall that the Diamantis P is a feeder containership that was built in 1998. The transaction is expected to result in a gain on sale of ~$10.2 million.

Spin-off transaction. Recall that Euroseas announced its intention to spin off three of its subsidiaries, two owning the M/V Aegean Express and M/V Joanna, and one that owned the M/V Diamantis P (prior to its sale) into Euroholdings Ltd. In exchange, Euroseas will receive 100% of the shares of Euroholdings Ltd., which will then be distributed to its shareholders (please refer to our note dated January 3 for transaction details).

Get the Full Report

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

Apple Faces Challenges Amid Downgrades: Weak iPhone Sales and AI Outlook Impact Stock

Posted on January 21, 2025January 21, 2025 by slightbourne@noblecapitalmarkets.com

Key Points:
– Jefferies cut Apple to “Underperform” with a price target of $200.75, while Loop Capital downgraded it to “Hold” at $230.
– Declining sales in China and a 1% dip in market share are major concerns for Apple’s flagship product.
– Apple’s AI initiatives, including Apple Intelligence, have not generated the anticipated sales supercycle, dampening investor enthusiasm.

Apple Inc. (AAPL) is grappling with significant challenges as analysts issue downgrades to its stock, citing weaker-than-expected iPhone sales and underwhelming performance in its artificial intelligence (AI) initiatives. The stock fell 3.82% on Tuesday following these reports, adding to mounting concerns about the tech giant’s ability to sustain its growth trajectory in an increasingly competitive market.

Jefferies analyst Edison Lee downgraded Apple to “Underperform” and slashed the price target to $200.75, a 13% reduction. Meanwhile, Loop Capital downgraded the stock from “Buy” to “Hold” and revised its target to $230, down from $275. Both firms point to headwinds in Apple’s core iPhone business and tepid consumer interest in AI-powered products as key factors behind their decisions.

The iPhone, which accounts for over half of Apple’s total revenue, is facing significant challenges. According to Jefferies, iPhone sales in China dropped by 15% to 20% year over year. This decline reflects both increased competition from local players like Huawei and Xiaomi and cautious consumer spending amid a slower Chinese economic recovery.

China has long been a critical market for Apple, contributing $66.9 billion in revenue in 2024, despite an 8% decline compared to the previous year. However, the company’s difficulties in this region are not new; Apple has struggled with currency fluctuations and declining sales for the past two years.

Globally, Apple’s iPhone market share fell by roughly 1% in Q4, landing at 23%, even as overall smartphone shipments rose by 3%. These numbers, provided by Canalys and IDC, underscore the growing competition Apple faces as it tries to maintain dominance in a crowded market.

Apple’s push into AI has also been a point of contention among analysts. The company debuted its AI platform, Apple Intelligence, in October 2024, marketing it as a transformative tool for its flagship devices. However, the staggered rollout has led to confusion among consumers, with many unaware of the platform’s full capabilities.

Jefferies had predicted that Apple Intelligence would drive a “sales supercycle,” but early indications suggest that adoption has been slow. This is a stark contrast to the success of other tech giants like Alphabet and Meta, whose innovative AI initiatives have helped drive their stock prices up 30% and 36%, respectively, over the past year.

The slow uptake of AI-powered devices further complicates Apple’s outlook, as the company seeks to diversify its revenue streams beyond the iPhone. While Apple’s Services segment remains a bright spot, generating $96.1 billion in 2024, the company will need to demonstrate sustained growth in other areas to regain investor confidence.

Despite these challenges, Apple has several opportunities to stabilize its position. The upcoming launch of a new iPhone SE, entry-level iPads, and MacBook Airs may provide a much-needed boost in mid-range and budget segments. Additionally, Apple’s brand loyalty and reputation for innovation could help it weather short-term setbacks.

The company is set to report its first-quarter earnings on January 30. Analysts and investors will be watching closely to see if Apple can reverse its recent trends and reestablish itself as a leader in both hardware and emerging technologies like AI.

Release – MustGrow Announces Closing of Private Placement of Units for $2,585,000

Posted on January 17, 2025January 17, 2025 by dburczyk@noblecapitalmarkets.com

Research News and Market Data on MGROF

SASKATOON, Saskatchewan, Canada, January 16, 2025 – MustGrow Biologics Corp. (TSXV:MGRO) (OTC:MGROF) (FRA:0C0) (the “Company” or “MustGrow“) is pleased to announce the closing of the previously announced non-brokered private placement of units (each, a “Unit“) at a price per Unit of $1,000 for aggregate gross proceeds to the Company of $2,585,000 (the “Private Placement“) on January 16, 2025 (the “Closing Date“).

Each Unit is comprised of: (i) $1,000 principal amount of unsecured convertible debentures (the “Debentures“); and (ii) 666 common share purchase warrants (the “Unit Warrants“). Each Debenture may, at the option of the holder: (i) be converted into common shares in the capital of the Company (the “Common Shares“) at price of $1.50 per Common Share (the “Principal Conversion Price“) at any time; or (ii) paid in cash 60 months following the Closing Date (subject to certain acceleration rights). Each Unit Warrant is exercisable by the holder thereof to acquire one Common Share at a price of $1.90 per Common Share for a period of 60 months following the Closing Date. The Debentures accrue interest at a rate of 8% per annum, payable semi-annually in cash.

If, at any time following the date that is 12 months from the Closing Date, the daily volume weighted average trading price of the Common Shares on the TSX Venture Exchange (the “TSXV“) is greater than $3.00 for the preceding 30 consecutive trading days, the Company shall have the option to immediately accelerate the conversion of the Debentures at the Principal Conversion Price.

In connection with the Private Placement, certain finders received an aggregate cash fee of $67,200. In addition, the Company issued to certain finders an aggregate of 44,800 non-transferable finder’s warrants (the “Finder Warrants“). Each Finder Warrant will entitle the holder thereof to purchase one Common Share at an exercise price of $1.90 per Common Share for a period of 24 months following the Closing Date.

The Company intends to use the proceeds from the Private Placement for inventory production for TerraSante^TM, working capital and general corporate purposes.

The Debentures, the Unit Warrants, the Finder Warrants, and any underlying Common Shares issued pursuant to those securities are subject to a four month plus one day hold period from the Closing Date. The Private Placement remains subject to final approval of the TSX Venture Exchange (the “TSXV“).

Certain insiders of the Company have subscribed for 300 Units under the Private Placement for aggregate gross proceeds of $300,000. Each subscription by an “insider” is considered to be a “related party transaction” for purposes of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“). The Company did not file a material change report more than 21 days before the Closing Date as the details of the Private Placement and the participation therein by each “related party” of the Company were not settled until shortly prior to the closing of the Private Placement, and the Company wished to close the Private Placement on an expedited basis for sound business reasons. The Company is relying on exemptions from the formal valuation and minority shareholder approval requirements available under MI 61-101. The Company is exempt from the formal valuation requirement in section 5.4 of MI 61-101 in reliance on section 5.5(a) of MI 61-101 as the fair market value of the transaction, insofar as it involves interested parties, is not more than the 25% of the Company’s market capitalization. Additionally, the Company is exempt from minority shareholder approval requirement in section 5.6 of MI 61-101 in reliance on section 5.7(b) of MI 61-101 as the fair market value of the transaction, insofar as it involves interested parties, is not more than the 25% of the Company’s market capitalization.

This press release does not constitute, and shall not be construed as, an offer to sell or a solicitation of an offer to buy any Units within the United States.

About MustGrow

MustGrow Biologics Corp. is a fully-integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company’s proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, MustGrow offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow’s wholly-owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers. Outside of North America, MustGrow is focused on collaborating with agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize MustGrow’s wholly-owned proprietary products and technologies. The Company is dedicated to driving shareholder value through on the commercialization and expansion of its intellectual property portfolio of approximately 112 patents that are currently issued and pending, and the sales and distribution of its proprietary and third-party product lines through NexusBioAg. MustGrow is a public traded company (TSXV-MGRO) and has approximately 51.6 million common shares issued and outstanding and 59.2 million shares fully diluted. For further details, please visit www.mustgrow.ca.

Contact Information

Corey Giasson
Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca

MustGrow Forward-Looking Statements

Certain statements included in this news release constitute “forward-looking statements” which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.

Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, “occur” or “be achieved”. Examples of forward-looking statements in this news release include, among others, statements MustGrow makes regarding: the receipt of final approval of the TSXV; and the use of proceeds from the Private Placement. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include: the receipt of final approval by the TSXV and those risks described in more detail in MustGrow’s Annual Information Form for the year ended December 31, 2023 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available on SEDAR+ at www.sedarplus.ca. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.

Neither the TSXV, nor their Regulation Services Provider (as that term is defined in the policies of the TSXV), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.

Supreme Court Upholds TikTok Ban Law, Putting App’s Future in Trump’s Hands

Posted on January 17, 2025January 17, 2025 by slightbourne@noblecapitalmarkets.com

In a landmark decision, the Supreme Court has upheld a law that would effectively ban TikTok in the United States by January 19 unless the social media platform is sold to an owner not controlled by a foreign adversary. The ruling places the fate of the app, used by 170 million Americans, in the hands of President-elect Donald Trump, who takes office on January 20.

The Court sided with the government’s position that ByteDance’s ties to China pose national security concerns, rejecting TikTok’s First Amendment arguments. While acknowledging the platform’s significance, the Court emphasized Congress’s authority to address national security threats. “There is no doubt that, for more than 170 million Americans, TikTok offers a distinctive and expansive outlet for expression, means of engagement, and source of community,” the Court stated, but concluded that the security concerns outweighed these considerations.

Trump, who previously promised to “save TikTok,” now holds significant influence over the app’s future. “It ultimately goes up to me, so you’re going to see what I’m going to do,” Trump told CNN following the Court’s decision. He has reportedly discussed the matter with Chinese President Xi Jinping and is considering various options, including an executive order that would delay the ban’s enforcement by 60 to 90 days.

The implementation of the ban would have far-reaching consequences for the tech industry. Major companies like Apple and Google would be prohibited from offering TikTok in their app stores, while cloud providers such as Microsoft, Amazon, and Oracle would be barred from hosting the service. Violations could result in penalties of up to $5,000 for each instance of US user access.

Several potential solutions have emerged as stakeholders scramble to prevent a shutdown. Chinese officials have reportedly discussed selling TikTok’s US operations to Elon Musk, owner of X, although their preference is to maintain ByteDance’s ownership. Additionally, a consortium led by billionaire Frank McCourt Jr. and including “Shark Tank” star Kevin O’Leary has expressed interest in acquiring the platform for up to $20 billion. “There’s a deal to be made here so that US TikTok can stay in business,” McCourt stated recently.

The ruling’s impact extends beyond TikTok itself, potentially reshaping the competitive landscape of social media. Industry analysts predict significant benefits for established platforms if TikTok exits the US market. William Blair research analyst Ralph Schackart estimates that Meta’s Instagram could capture 60-70% of TikTok’s advertising revenue, noting that Instagram “monetizes at around 3x the rate of TikTok.” Similarly, Morgan Stanley projects that YouTube’s Shorts platform could gain $400-750 million in ad revenue for every 10% of former TikTok user time it captures.

As the situation develops, legislative solutions are also being explored. Senator Ed Markey has introduced a bill that would extend the divestiture deadline by 270 days, potentially providing crucial additional time for negotiations. Trump’s incoming administration has multiple options, including pushing Congress to overturn the law, encouraging an extension of the deadline, or facilitating a sale of the US operations.

As the January 19 deadline approaches, the tech industry, millions of users, and the advertising market await clarity on whether Trump’s administration will enforce the ban, negotiate a sale, or find another solution to keep the popular platform operating in the United States. The outcome of this high-stakes situation will likely set important precedents for foreign-owned technology companies operating in the US market.

Bitcoin Surges Past $100,000 as Trump’s Pro-Crypto Presidency Looms

Posted on January 17, 2025January 17, 2025 by slightbourne@noblecapitalmarkets.com

Key Points:
– Bitcoin hits $104,000, marking a 420% increase from its $20,000 price two years ago
– Trump names David Sacks as crypto “czar” and plans regulatory overhaul
– Administration aims to create $21 billion Strategic Bitcoin Reserve

Bitcoin’s price surged past $100,000 on Friday as cryptocurrency markets anticipate major policy shifts under President-elect Donald Trump’s incoming administration. The world’s leading cryptocurrency rose approximately 5% to $104,000, reflecting growing optimism about Trump’s promised pro-crypto agenda.

Trump, who once dismissed bitcoin as a “scam,” has undergone a dramatic shift in his stance toward digital currencies. His campaign promises include transforming the United States into the global “crypto capital,” with specific plans for industry-friendly regulations and the establishment of a government cryptocurrency stockpile.

The president-elect has already begun assembling a team of crypto advocates for key positions, including David Sacks as the administration’s cryptocurrency “czar” and Bo Hines as executive director of the Presidential Council of Advisers for Digital Assets. Paul Atkins, Trump’s pick to lead the SEC, has been a vocal supporter of cryptocurrencies, signaling a stark departure from the regulatory approach of the Biden administration.

One of Trump’s most ambitious proposals is the creation of a Strategic Bitcoin Reserve, which would require the Treasury Department to maintain at least $21 billion in bitcoin through its Exchange Stabilization Fund. This initiative would represent a significant shift in government policy, as historically, the U.S. has auctioned off cryptocurrency seized in law enforcement operations.

The cryptocurrency industry, which felt targeted by outgoing SEC Chairman Gary Gensler’s enforcement actions, has welcomed these developments. Peter Van Valkenburgh, executive director of Coin Center, expressed optimism about the expected “tone change at the SEC” under the new administration.

The industry’s enthusiasm is evident in the organization of the first-ever “Crypto Ball,” a sold-out celebration featuring “an elite lineup of musical entertainment” to mark the inauguration of what supporters are calling the first “crypto president.”

However, critics continue to raise concerns about cryptocurrency’s volatile nature and its potential use in illegal activities. Despite these reservations, bitcoin has demonstrated remarkable resilience, with its value increasing dramatically from around $20,000 two years ago to its current record levels.

As Trump prepares to take office on January 20, the cryptocurrency market eagerly awaits the implementation of his promised policies, which could reshape the regulatory landscape for digital assets in the United States.

Take a moment and take a look at Bitcoin Depot and Bit Digital in the cryptocurrency space.

Rising Mortgage Rates Continue to Challenge Homebuyers and Housing Market Recovery

Posted on January 16, 2025January 16, 2025 by slightbourne@noblecapitalmarkets.com

Key Points:
– The average rate on a 30-year mortgage has risen to 7.04%, its highest level since May, marking its fifth consecutive increase.
– Higher mortgage rates, driven by climbing bond yields, have led to increased borrowing costs, discouraging homebuyers and prolonging the housing market slump.
– Despite a slight rise in home sales in November, 2024 is expected to be the worst year for home sales since 1995, with affordability concerns continuing to impact the market.

The average rate on a 30-year mortgage has surged to 7.04%, marking its highest level since May and its fifth consecutive weekly increase. This rise in borrowing costs has left homebuyers facing higher monthly payments, potentially pricing many out of the housing market and prolonging an already sluggish real estate landscape.

According to mortgage buyer Freddie Mac, the rate has steadily climbed from 6.93% last week and has seen a significant jump from 6.6% a year ago. The increase is largely driven by higher bond yields, particularly the yield on the U.S. 10-year Treasury, which has surged from 3.62% in mid-September to 4.61% this week. Higher bond yields often lead to higher mortgage rates, as lenders use these benchmarks to set their borrowing costs.

The rising cost of home loans is particularly impactful on first-time buyers and those looking to refinance their homes at a lower rate. For many, the monthly payments associated with higher mortgage rates could amount to hundreds of dollars more, making homeownership less affordable. This shift has already begun to cool down demand, with fewer buyers in the market and a prolonged national home sales slump.

In fact, sales of previously owned homes have risen slightly in recent months, but the housing market is still on track to report its worst year for home sales since 1995. Despite the slight uptick in sales in November, analysts warn that full-year sales figures could be disappointing, reflecting the sharp slowdown in activity. This decline has been fueled by the steady rise in mortgage rates, which began climbing following signals from the Federal Reserve last year.

The Fed’s decision to curb anticipated interest rate cuts, in response to stubbornly high inflation and economic uncertainties, has further contributed to higher borrowing costs. With inflation still above the central bank’s 2% target and economic policies under a new administration potentially fueling costs, the rise in mortgage rates seems likely to persist.

For prospective homebuyers, these higher borrowing costs mean that affordability continues to shrink, particularly in an environment of rising home prices and limited housing inventory. Many are now opting to hold off on purchasing until either rates stabilize or decline.

Overall, the real estate market appears poised for continued challenges in 2025, as elevated mortgage rates and affordability concerns weigh on buyer demand and slow down housing market recovery. The outlook remains uncertain, with potential policy shifts and economic pressures playing a significant role in determining the future course of rates and housing activity.

Release – Ocugen, Inc. Announces First Patient Dosed in Phase 1 Clinical Trial of OCU200—a Novel Integrin-Targeting Biologic for Diabetic Macular Edema

Posted on January 16, 2025January 16, 2025 by aweinsoff@channelchek.com

Research News and Market Data on OCGN

January 16, 2025

PDF Version

MALVERN, Pa., Jan. 16, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME).

“OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and wet age-related macular degeneration (wet AMD) with its unique mechanism of action, binding the active component—tumstatin—to integrin receptors that play a crucial role in disease pathogenesis,” said Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen. “OCU200 holds the promise to benefit all DME patients, including the 30-40% of patients who do not respond to current anti-VEGF therapies.”

The OCU200 Phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal injection in three cohorts: low dose (0.025 mg), medium dose (0.05 mg), and high dose (0.1 mg). All subjects will receive a total of two intravitreal injections of OCU200 six weeks apart. Patient follow-up will take place up to three months after the last injection.

Approximately 12 million people in the United States and 130 million people worldwide are affected by DME, DR or wet AMD. Patients affected by these diseases share common symptoms, such as blurriness in vision and progressive vision loss as the disease progresses. The formation of fragile and leaky new blood vessels leads to fluid accumulation in and around the retina, causing damage to vision.

“I am seeing an increasing rate of vision-threatening diseases associated with diabetes at my clinic and am eager to provide a new therapeutic option to these patients,” said Dr. David Almedia, Vitreoretinal Surgeon and Clinician Scientist, President and CEO of Erie Retina Research, and Founder and President of Case X Global in Erie, Pennsylvania. “There remains a considerable unmet medical need for DME and DR patients with currently available anti-VEGF treatments.”

OCU200 is a recombinant fusion protein that consists of two parts connected by a linker: tumstatin, the active component, acts as an anti-inflammatory, anti-VEGF agent by binding to integrin receptors; and transferrin, which targets the drug to the choroid and retina by binding transferrin receptors on endothelial cells. These features will potentially enable OCU200 to reduce the vascular permeability, inflammation, and neovascularization that drive the pathophysiology of DME, DR, and wet AMD at a significantly lower dose compared to currently approved therapies.

“We are enthusiastic about getting patients started in the OCU200 Phase 1 clinical trial and sharing not only safety but preliminary efficacy data as the study progresses,” said Dr. Huma Qamar, Chief Medical Officer at Ocugen. “OCU200 brings an innovative biologic candidate to Ocugen’s ophthalmology portfolio targeting blindness diseases.”

The Company intends to pursue approval to use OCU200 as a first-line therapy for DME, DR, and wet AMD.

About Ocugen, Inc.
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients’ lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. Discover more at www.ocugen.com and follow us on X and LinkedIn.

Cautionary Note on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding qualitative assessments of available data, potential benefits, expectations for ongoing clinical trials, anticipated regulatory filings and anticipated development timelines, which are subject to risks and uncertainties. We may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from our current expectations, including, but not limited to, the risks that preliminary, interim and top-line clinical trial results may not be indicative of, and may differ from, final clinical data; the ability of OCU200 to perform in humans in a manner consistent with nonclinical or preclinical study data; that unfavorable new clinical trial data may emerge in ongoing clinical trials or through further analyses of existing clinical trial data; that earlier non-clinical and clinical data and testing of may not be predictive of the results or success of later clinical trials; and that that clinical trial data are subject to differing interpretations and assessments, including by regulatory authorities. These and other risks and uncertainties are more fully described in our periodic filings with the Securities and Exchange Commission (SEC), including the risk factors described in the section entitled “Risk Factors” in the quarterly and annual reports that we file with the SEC. Any forward-looking statements that we make in this press release speak only as of the date of this press release. Except as required by law, we assume no obligation to update forward-looking statements contained in this press release whether as a result of new information, future events, or otherwise, after the date of this press release.

Contact:
Tiffany Hamilton
Head of Communications
Tiffany.Hamilton@ocugen.com

SKYX Platforms (SKYX) – A Step Forward for Its Commercial Distribution Channel

Posted on January 16, 2025January 16, 2025 by cpereira@noblefcm.com

Thursday, January 16, 2025

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Commercial expansion. On January 15th, the company announced that it will begin supplying its products to real estate developer Jeremiah Baron Companies. The developer has mixed-use residential and commercial projects underway in Florida. The partnership is expected to encompass approximately 1,000 units, which we believe equates to roughly 30,000 receptacles.

Seeding for the future. The company will initially supply receptacles to the developer, followed by plug-in products in the later stages of development, such as chandeliers, ceiling fans, and others. Importantly, the company’s fixtures, which plug into the receptacles, sell at higher prices. As such, we expect initial revenue impacts from the partnership to be modest, followed by a more meaningful impact when the units are ready for the installation of plug-in products. We anticipate that the development of the mixed-use project will extend into 2026.

Get the Full Report

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

Electric Revolution: EVs and Hybrids Hit Historic 20% Market Share in US Auto Sales

Posted on January 16, 2025January 16, 2025 by slightbourne@noblecapitalmarkets.com

Key Points:
– Over 3.2 million electrified vehicles sold in 2024
– Tesla maintains EV leadership despite market share drop to 49%
– Traditional combustion engine sales fall below 80% for first time

The U.S. automotive industry achieved a significant milestone in 2024, with electric and hybrid vehicles reaching 20% of the total market share for the first time, according to new data from Motor Intelligence. This marks a turning point in the evolution of consumer preferences, signaling a transition toward sustainable transportation options. While the shift to electrified vehicles has been slower than expected by some industry analysts, the data confirms that the momentum behind electrification is undeniable.

A total of more than 3.2 million electrified vehicles were sold last year, with hybrid vehicles—including plug-in models—accounting for 1.9 million units, and pure electric vehicles (EVs) making up 1.3 million sales. This surge has driven traditional internal combustion engine vehicles below the 80% market share threshold for the first time in modern automotive history, further emphasizing the growing importance of electrification in the U.S. automotive sector.

Tesla remains the dominant force in the EV market, despite a slight decline in its market share from 55% in 2023 to around 49% in 2024. While this drop may raise some eyebrows, it highlights the expanding competitiveness in the EV space rather than a downturn in Tesla’s performance. In fact, Tesla’s Model Y and Model 3 retained their positions as the bestselling electric vehicles in the U.S., continuing to set the pace for the industry.

The shift in Tesla’s market share also reflects an influx of new competitors entering the EV market. Hyundai Motor Group, including Kia, secured second place with 9.3% of the market, followed by General Motors at 8.7%, Ford at 7.5%, and BMW at 4.1%. This competition is reshaping the investment landscape, with traditional automakers like Ford and GM making aggressive pushes into the EV market, while luxury brands like BMW tap into the demand for high-end electrified models.

The evolving EV market is creating both opportunities and challenges for investors. The increasing competition, driven by both established automakers and new entrants, is a key factor reshaping the investment dynamics within the electric vehicle sector. Companies that are able to secure significant market share in the EV space, such as Tesla, GM, and Hyundai, are well-positioned to capitalize on the ongoing transition. At the same time, investors must remain vigilant to the competitive pressures that could impact individual companies’ performance, especially as the market continues to mature.

The 2024 data shows that the pace of electrification is accelerating, with over 68 mainstream EV models tracked by Cox’s Kelley Blue Book, and 24 of them showing year-over-year sales growth. The number of new models entering the market (17 in 2024) reflects the increasing commitment of manufacturers to the electric vehicle sector. Yet, it also underscores the need for companies to innovate and differentiate themselves in a crowded marketplace.

Looking ahead, the outlook for 2025 is promising. With projections for EV sales to potentially hit 10% of all new vehicle sales, and electrified vehicles (EVs and hybrids) possibly making up 25% of all new cars sold, the industry is poised for continued growth. However, the investment landscape could be impacted by policy changes, such as the potential reconsideration of the $7,500 federal tax credit for EVs under a new administration. Any changes to such incentives could influence future adoption rates and, in turn, investor sentiment in the electric vehicle market.

In conclusion, the electric vehicle market is undergoing a profound transformation, reshaping the U.S. automotive industry and the broader investment landscape. As more consumers make the switch to electrified vehicles and new players enter the market, investors will need to stay informed and strategically assess the opportunities and risks associated with this rapidly evolving sector.